Pacific Edge: 1H20 Result and Capital Raise
Pacific Edge 1H20 Result and Capital Raise Pacific Edge (PEB) announced a fully underwritten NZ$20m capital raise alongside its 1H20 result, as it...
1k Views
Pacific Edge - Anticipating commercial growth
Pacific Edge continues to make progress commercialising its suite of bladder cancer diagnostics products, with three tests currently available in...
214 Views
A growth year
Pacific Edge continues to make progress in the commercialisation of its bladder cancer diagnostics tests, reporting 35% growth in the number of...
291 Views
Launches continue to progress
Pacific Edge continues to make progress in the commercialisation of its bladder cancer diagnostics tests in the US, with three tests currently...
157 Views